As we previously reported, the Centers for Medicare & Medicaid Services (CMS) announced in November that it would cover monoclonal antibody therapies approved by the Food and Drug Administration to treat COVID-19 patients. On December 9, 2020, CMS posted updates to its COVID-19 FAQs on Medicare FFS Billing about coverage and payment for monoclonal antibodies treatments and published a Therapeutics Coverage Infographic on coverage of monoclonal antibody therapies. The comprehensive source for CMS communications and instruction on monoclonal antibody therapy coverage is available here.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.